Sign in Create account
Sign in and upgrade to a paid plan to export corporate actions as CSV.

Dr.Datsons Labs Limited

BSE: 533412
₹6.29
▼ -0.33 (-4.98%)
May 21, 2015 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
10/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
5.9
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 6.2900 · High 6.2900
1W return
-36.7%
Low 6.2900 · High 8.0000
1M return
-60.6%
Low 6.2900 · High 18.4600
52W return
-67.8%
Low 5.4800 · High 21.5000
Lifetime High ₹844.8500 (Jan. 18, 2013)
Lifetime Low ₹5.6200 (March 27, 2015)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
7.6
10D
9.2
20D
10.4
50D
10.2
100D
10.1
200D
11.1

Delivery and volume

Day avg. delivery
99.2%
Week avg. delivery
57.4%
Month avg. delivery
46.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

6.29
Pivot
First resistance6.29
Second resistance6.29
Third resistance6.29
First support6.29
Second support6.29
Third support6.29
Day RSI29.8
Day MFI74.0
Day MACD-0.94
Day MACD signal0.16

Beta

1M-3.03
3M-0.59
1Y0.70
3Y0.67

Price change analysis

↓ -60.6%
Over 1 Month
LowHigh
6.2918.46
↓ -2.6%
Over 3 Months
LowHigh
5.4818.46
↓ -49.2%
Over 6 Months
LowHigh
5.4818.46
↓ -67.8%
Over 1 Year
LowHigh
5.4821.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →

Data unavailable.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

Deals (Bulk & Block)

All 292 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
6 May 2015 JMP SECURITIES PVT LTD Bulk Buy 424,206 11.6600 BSE
6 May 2015 JMP SECURITIES PVT LTD Bulk Sell 561,583 11.2300 BSE
30 Apr 2015 CHETAN RASIKLAL SHAH Bulk Sell 112,411 13.6400 BSE
30 Apr 2015 CHETAN RASIKLAL SHAH Bulk Buy 847,075 13.6400 BSE
16 Apr 2015 ADROIT FINANCIAL SERVICES PRIVATE LIMITED Bulk Buy 819,145 13.5300 BSE
16 Apr 2015 ADROIT FINANCIAL SERVICES PRIVATE LIMITED Bulk Sell 855,466 13.4800 BSE
10 Apr 2015 ADROIT FINANCIAL SERVICES PRIVATE LIMITED Bulk Buy 564,341 10.3700 BSE
10 Apr 2015 ADROIT FINANCIAL SERVICES PRIVATE LIMITED Bulk Sell 636,466 10.3800 BSE
8 Apr 2015 SHIV KUMAR Bulk Buy 5,000 8.2200 BSE
8 Apr 2015 SHIV KUMAR Bulk Sell 955,000 8.1600 BSE

All bulk and block deals →

Dividends

Full dividend history →
Ex-dateSubjectPer share (₹)Record date
20 Sep 2013 Annual General Meeting/Dividend Re 0.10/- Per Share 0.1000 —
31 Aug 2012 Annual General Meeting And Dividend Rs.2/- Per Share 2.0000 —

Corporate Actions

Full history (5 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from AANJANEYA LIFECARE LTD. to Dr.Datsons Labs Limited
22 Sep 2014OTHERAnnual General Meeting
21 Sep 2011OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 178 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
18 Jun 2018 Delisting Members of the Exchange are hereby notified that in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye Laws & Regulations of National Stock Exchange of India Limited, it has been decided to delist (withdraw the admission to dealings in) equity shares of the Dr. Datson's Labs Limited w.e.f. July 02, 2018.
2 Feb 2018 Public Notice - Compulsory Delisting Members of the Exchange are hereby informed that the Exchange on February 02, 2018 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).
18 May 2015 Suspension of Trading Members of the Exchange are hereby informed that trading in the equity shares of Dr. Datson's Labs Limited will be suspended w.e.f. May 22, 2015 (i.e. closing hours of trading on May 21, 2015) pursuant to order dated 18/02/2015 passed by the Hon ble High Court, Bombay, in Company Petition No. 328 of 2014, the Official Liquidator attached to the said Court has been appointed as the Provisional Liquidator of M/s Dr. Datson's Labs Limited.
15 May 2015 Updates Dr. Datson's Labs Limited has informed the Exchange that the Company to submit order copy of Bombay High Court dated February 18, 2015 (uploaded on website on March 27, 2015) and Minutes Copy of Official Liquidator dated April 30, 2015.
12 May 2015 Resignation of Company Secretary/Compliance Officer Dr. Datson's Labs Limited has informed the Exchange that Mr. Yogesh Patel, has resigned from the post of Company Secretary & Compliance Officer of the Company with effect from May 12, 2015.
7 May 2015 Updates Dr. Datson's Labs Limited has informed the Exchange that the creditors of the Company in winding up petitions, vide its order dated February 18, 2015 (uploaded on website on March 27, 2015), appointed the official liquidator attached to the Bombay High Court as the provisional liquidator of Dr. Datsons Labs Limited (the Company ) and directed the provisional liquidator to forthwith take charge/possession of the Company s assets, properties, stock in trade, books of account, bank account and all other assets of the Company.
13 Apr 2015 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Finaventure Capital Limited has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
13 Apr 2015 Disc. under Reg.30 of SEBI (SAST) Reg.2011 Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated April 10, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
10 Apr 2015 Clarification The Exchange had sought clarification from Dr. Datson's Labs Limited with respect to "Spurt in Price and Volume". The Company has submitted its clarification for the same.
6 Apr 2015 Appointment of Director Dr. Datson's Labs Limited has informed the Exchange that Ms. Anjali Jadhav, has been appointed as a Non Executive Additional Director of the Company, with effect from April 2, 2015.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (29.8) -- a technical rebound zone

Threats

  • Down 67.8% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Dr.Datsons Labs Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.